Center Laboratories, Inc. (TPEX:4123)
24.65
-1.55 (-5.92%)
Nov 20, 2026, 1:30 PM CST
Center Laboratories Market Cap
Center Laboratories has a market cap or net worth of 19.5 billion as of November 20, 2026. It is the 12,589th most valuable company in the world and the 352nd biggest in Taiwan. Its market cap has decreased by 26.74% in one year.
Market Cap
19.50B
Enterprise Value
21.56B
Revenue
1.78B
Global Rank
Country Rank
#352 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since November 3, 2004, Center Laboratories's market cap has increased from 358.01M to 19.50B, an increase of 5,346.31%. That is a compound annual growth rate of 19.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 19.50B | -37.21% |
| Dec 31, 2025 | 31.06B | -1.69% |
| Dec 31, 2024 | 31.59B | 3.14% |
| Dec 29, 2023 | 30.63B | 8.88% |
| Dec 30, 2022 | 28.13B | -7.93% |
| Dec 30, 2021 | 30.56B | -3.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bora Pharmaceuticals | 35.64B |
| Lotus Pharmaceutical | 27.04B |
| TTY Biopharm Company | 19.27B |
| YungShin Global Holding | 15.08B |
| Handa Pharmaceuticals | 13.38B |
| ScinoPharm Taiwan | 13.32B |
| Synmosa Biopharma | 13.15B |
| Foresee Pharmaceuticals | 10.54B |